{"parse":{"title":"Serious adverse event","pageid":2234566,"revid":859481556,"text":{"*":"<div class=\"mw-parser-output\"><p>A <b>serious <a href=\"/wiki/Adverse_event\" title=\"Adverse event\">adverse event</a></b> (SAE) in human <a href=\"/wiki/Drug\" title=\"Drug\">drug</a> trials is defined as any untoward\nmedical occurrence that at any dose \n</p>\n<ol><li>results in death,</li>\n<li>is <a href=\"/wiki/Death\" title=\"Death\">life-threatening</a></li>\n<li>requires inpatient <a href=\"/wiki/Inpatient_care\" title=\"Inpatient care\">hospitalization</a> or causes prolongation of existing hospitalization</li>\n<li>results in persistent or significant disability/incapacity,</li>\n<li>may have caused a congenital anomaly/birth defect, or</li>\n<li>requires intervention to prevent permanent impairment or damage.<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup></li></ol>\n<p>The term \"life-threatening\" in the definition of \"serious\" refers to an event in which the patient was at risk of death at the time of the event; it does not refer to an event which hypothetically might have caused death if it were more severe.<sup id=\"cite_ref-Defs_2-0\" class=\"reference\"><a href=\"#cite_note-Defs-2\">&#91;2&#93;</a></sup> <a href=\"/wiki/Adverse_event\" title=\"Adverse event\">Adverse events</a> are further defined as \u201cAny untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment.\u201d<sup id=\"cite_ref-Defs_2-1\" class=\"reference\"><a href=\"#cite_note-Defs-2\">&#91;2&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Research\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Research</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Related_Terms\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Related Terms</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Footnotes\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Footnotes</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#External_links\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Research\">Research</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Serious_adverse_event&amp;action=edit&amp;section=1\" title=\"Edit section: Research\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Investigators in human clinical trials are obligated to report these events in clinical study reports.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> Research suggests that these events are often inadequately reported in publicly available reports.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> Because of the lack of these data and uncertainty about methods for synthesising them, individuals conducting <a href=\"/wiki/Systematic_review\" title=\"Systematic review\">systematic reviews</a> and meta-analyses of therapeutic interventions often unknowingly overemphasise health benefit.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>   To balance the overemphasis on benefit, scholars have called for more complete reporting of harm from clinical trials.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Related_Terms\">Related Terms</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Serious_adverse_event&amp;action=edit&amp;section=2\" title=\"Edit section: Related Terms\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Serious adverse reactions are serious adverse events judged to be related to drug therapy.  A SUSAR (suspected unexpected serious adverse reaction) should be reported to a drug regulatory authority under an investigational license by using the <a href=\"/wiki/Council_for_International_Organizations_of_Medical_Sciences\" title=\"Council for International Organizations of Medical Sciences\">CIOMS</a> form (or in some countries an equivalent form).  \"Unexpected\" means that for an authorised (approved) medicinal product that the event is not described in the product's labeling, or in the case of an investigational (unapproved) product that the event is not listed in the <a href=\"/wiki/Investigator%27s_Brochure\" class=\"mw-redirect\" title=\"Investigator&#39;s Brochure\">Investigator\u2019s Brochure</a>.\n</p><p>An <a href=\"/wiki/Adverse_effect\" title=\"Adverse effect\">adverse effect</a> is an adverse event which is believed to be caused by a health intervention.\n</p>\n<h2><span class=\"mw-headline\" id=\"Footnotes\">Footnotes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Serious_adverse_event&amp;action=edit&amp;section=3\" title=\"Edit section: Footnotes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.fda.gov/safety/medwatch/howtoreport/ucm053087.htm\">http://www.fda.gov/safety/medwatch/howtoreport/ucm053087.htm</a></span>\n</li>\n<li id=\"cite_note-Defs-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Defs_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Defs_2-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Expert Working Group (Efficacy) of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). (August 25, 2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/cder/guidance/iche2a.pdf\">\"Guideline for Industry - Clinical safety data management: definitions and standards for expedited reporting\"</a> <span style=\"font-size:85%;\">(PDF)</span>. FDA Center for Drug Evaluation and Research.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Guideline+for+Industry+-+Clinical+safety+data+management%3A+definitions+and+standards+for+expedited+reporting.&amp;rft.pub=FDA+Center+for+Drug+Evaluation+and+Research&amp;rft.date=2007-08-25&amp;rft.au=Expert+Working+Group+%28Efficacy%29+of+the+International+Conference+on+Harmonisation+of+Technical+Requirements+for+Registration+of+Pharmaceuticals+for+Human+Use+%28ICH%29.&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fcder%2Fguidance%2Fiche2a.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASerious+adverse+event\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Expert working group (efficacy) of the international conference on harmonization of technical requirements for registration of pharmaceuticals for human use (August 25, 2007). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/cder/guidance/iche3.pdf\">\"Guideline for Industry Structure and Content of Clinical Study Reports\"</a> <span style=\"font-size:85%;\">(PDF)</span>. FDA Center for Drug Evaluation and Research.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Guideline+for+Industry+Structure+and+Content+of+Clinical+Study+Reports.&amp;rft.pub=FDA+Center+for+Drug+Evaluation+and+Research&amp;rft.date=2007-08-25&amp;rft.au=Expert+working+group+%28efficacy%29+of+the+international+conference+on+harmonization+of+technical+requirements+for+registration+of+pharmaceuticals+for+human+use&amp;rft_id=http%3A%2F%2Fwww.fda.gov%2Fcder%2Fguidance%2Fiche3.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASerious+adverse+event\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ioannidis JP, Lau J (2001). \"Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas\". <i>JAMA</i>. <b>285</b> (4): 437\u201343. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.285.4.437\">10.1001/jama.285.4.437</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11242428\">11242428</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Completeness+of+safety+reporting+in+randomized+trials%3A+an+evaluation+of+7+medical+areas.&amp;rft.volume=285&amp;rft.issue=4&amp;rft.pages=437-43&amp;rft.date=2001&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.285.4.437&amp;rft_id=info%3Apmid%2F11242428&amp;rft.aulast=Ioannidis&amp;rft.aufirst=JP&amp;rft.au=Lau%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASerious+adverse+event\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chou R, Helfand M (2005). \"Challenges in systematic reviews that assess treatment harms\". <i>Ann Intern Med</i>. <b>142</b> (12 Pt 2): 1090\u20130. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.7326/0003-4819-142-12_part_2-200506211-00009\">10.7326/0003-4819-142-12_part_2-200506211-00009</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15968034\">15968034</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ann+Intern+Med&amp;rft.atitle=Challenges+in+systematic+reviews+that+assess+treatment+harms.&amp;rft.volume=142&amp;rft.issue=12+Pt+2&amp;rft.pages=1090-0&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-142-12_part_2-200506211-00009&amp;rft_id=info%3Apmid%2F15968034&amp;rft.aulast=Chou&amp;rft.aufirst=R&amp;rft.au=Helfand%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASerious+adverse+event\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ioannidis JP, Evans SJ, <a href=\"/wiki/Peter_C._G%C3%B8tzsche\" title=\"Peter C. G\u00f8tzsche\">G\u00f8tzsche PC</a>, O'Neill RT, Altman DG, Schulz K, Moher D, CONSORT Group (2004). \"Better reporting of harms in randomized trials: an extension of the CONSORT statement\". <i>Ann Intern Med</i>. <b>141</b> (10): 781\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.7326/0003-4819-141-10-200411160-00009\">10.7326/0003-4819-141-10-200411160-00009</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15545678\">15545678</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ann+Intern+Med&amp;rft.atitle=Better+reporting+of+harms+in+randomized+trials%3A+an+extension+of+the+CONSORT+statement.&amp;rft.volume=141&amp;rft.issue=10&amp;rft.pages=781-8&amp;rft.date=2004&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-141-10-200411160-00009&amp;rft_id=info%3Apmid%2F15545678&amp;rft.aulast=Ioannidis&amp;rft.aufirst=JP&amp;rft.au=Evans%2C+SJ&amp;rft.au=G%C3%B8tzsche%2C+PC&amp;rft.au=O%27Neill%2C+RT&amp;rft.au=Altman%2C+DG&amp;rft.au=Schulz%2C+K&amp;rft.au=Moher%2C+D&amp;rft.au=CONSORT+Group&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASerious+adverse+event\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Serious_adverse_event&amp;action=edit&amp;section=4\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"div-col columns column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em;\">\n<ul><li><a href=\"/wiki/Adverse_event\" title=\"Adverse event\">Adverse event</a>, including mild/minor</li>\n<li><a href=\"/wiki/Clinical_trial\" title=\"Clinical trial\">Clinical trial</a></li>\n<li><a href=\"/wiki/Good_clinical_practice\" title=\"Good clinical practice\">Good clinical practice</a> (GCP)</li>\n<li><a href=\"/wiki/Data_Monitoring_Committees\" class=\"mw-redirect\" title=\"Data Monitoring Committees\">Data Monitoring Committees</a></li>\n<li><a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">Pharmacovigilance</a></li>\n<li><a href=\"/wiki/EudraVigilance\" title=\"EudraVigilance\">EudraVigilance</a> (<a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a>)</li>\n<li><a href=\"/wiki/Directive_2001/20/EC\" class=\"mw-redirect\" title=\"Directive 2001/20/EC\">Directive 2001/20/EC</a> (<a href=\"/wiki/European_Union\" title=\"European Union\">European Union</a>)</li>\n<li><a href=\"/wiki/TGN1412\" class=\"mw-redirect\" title=\"TGN1412\">TGN1412</a>, a drug that had SAEs in a clinical trial</li>\n<li><a href=\"/wiki/BIA_10-2474\" title=\"BIA 10-2474\">BIA 10-2474</a>, a drug that had SAEs, including a fatality, in a clinical trial</li></ul>\n</div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Serious_adverse_event&amp;action=edit&amp;section=5\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fda.gov/medwatch/report/DESK/advevnt.htm\">What Is A Serious Adverse Event?</a> (MedWatch)</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.clinicaltrials.gov/\">ClinicalTrials.gov</a> from US <a href=\"/wiki/National_Library_of_Medicine\" class=\"mw-redirect\" title=\"National Library of Medicine\">National Library of Medicine</a></li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ich.org\">ICH Website</a></li></ul>\n\n<!-- \nNewPP limit report\nParsed by mw2255\nCached time: 20180914094117\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.124 seconds\nReal time usage: 0.146 seconds\nPreprocessor visited node count: 357/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 11106/2097152 bytes\nTemplate argument size: 182/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 7500/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.057/10.000 seconds\nLua memory usage: 2.39 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  117.379      1 -total\n 93.04%  109.208      1 Template:Reflist\n 53.60%   62.912      2 Template:Cite_web\n 22.66%   26.593      3 Template:Cite_journal\n  5.24%    6.149      1 Template:Div_col\n  2.43%    2.850      2 Template:Main_other\n  1.56%    1.827      1 Template:Div_col_end\n  1.53%    1.801      1 Template:Column-width\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:2234566-0!canonical and timestamp 20180914094116 and revision id 859481556\n -->\n</div>"},"langlinks":[{"lang":"de","url":"https://de.wikipedia.org/wiki/Schwerwiegendes_unerw%C3%BCnschtes_Ereignis","langname":"German","autonym":"Deutsch","*":"Schwerwiegendes unerw\u00fcnschtes Ereignis"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Acontecimiento_adverso_severo","langname":"Spanish","autonym":"espa\u00f1ol","*":"Acontecimiento adverso severo"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/%C3%89v%C3%A9nement_ind%C3%A9sirable_grave","langname":"French","autonym":"fran\u00e7ais","*":"\u00c9v\u00e9nement ind\u00e9sirable grave"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Ci%C4%99%C5%BCkie_zdarzenie_niepo%C5%BC%C4%85dane","langname":"Polish","autonym":"polski","*":"Ci\u0119\u017ckie zdarzenie niepo\u017c\u0105dane"}],"categories":[{"sortkey":"Serious Adverse Event","*":"Clinical_research"},{"sortkey":"Serious Adverse Event","*":"Pharmaceutical_industry"}],"links":[{"ns":0,"exists":"","*":"Adverse effect"},{"ns":0,"exists":"","*":"Adverse event"},{"ns":0,"exists":"","*":"BIA 10-2474"},{"ns":0,"exists":"","*":"Clinical trial"},{"ns":0,"exists":"","*":"Council for International Organizations of Medical Sciences"},{"ns":0,"exists":"","*":"Data Monitoring Committees"},{"ns":0,"exists":"","*":"Death"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Directive 2001/20/EC"},{"ns":0,"exists":"","*":"Drug"},{"ns":0,"exists":"","*":"EudraVigilance"},{"ns":0,"exists":"","*":"European Union"},{"ns":0,"exists":"","*":"Good clinical practice"},{"ns":0,"exists":"","*":"Inpatient care"},{"ns":0,"exists":"","*":"Investigator's Brochure"},{"ns":0,"exists":"","*":"National Library of Medicine"},{"ns":0,"exists":"","*":"Peter C. G\u00f8tzsche"},{"ns":0,"exists":"","*":"Pharmacovigilance"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Systematic review"},{"ns":0,"exists":"","*":"TGN1412"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Div col"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Div col end"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":[],"externallinks":["http://www.fda.gov/cder/guidance/iche2a.pdf","http://www.fda.gov/cder/guidance/iche3.pdf","//doi.org/10.1001/jama.285.4.437","//www.ncbi.nlm.nih.gov/pubmed/11242428","//doi.org/10.7326/0003-4819-142-12_part_2-200506211-00009","//www.ncbi.nlm.nih.gov/pubmed/15968034","//doi.org/10.7326/0003-4819-141-10-200411160-00009","//www.ncbi.nlm.nih.gov/pubmed/15545678","http://www.fda.gov/safety/medwatch/howtoreport/ucm053087.htm","http://www.fda.gov/medwatch/report/DESK/advevnt.htm","http://www.clinicaltrials.gov/","http://www.ich.org"],"sections":[{"toclevel":1,"level":"2","line":"Research","number":"1","index":"1","fromtitle":"Serious_adverse_event","byteoffset":1514,"anchor":"Research"},{"toclevel":1,"level":"2","line":"Related Terms","number":"2","index":"2","fromtitle":"Serious_adverse_event","byteoffset":3430,"anchor":"Related_Terms"},{"toclevel":1,"level":"2","line":"Footnotes","number":"3","index":"3","fromtitle":"Serious_adverse_event","byteoffset":4189,"anchor":"Footnotes"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"4","fromtitle":"Serious_adverse_event","byteoffset":4216,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"External links","number":"5","index":"5","fromtitle":"Serious_adverse_event","byteoffset":4642,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Serious adverse event","iwlinks":[],"properties":[{"name":"defaultsort","*":"Serious Adverse Event"},{"name":"wikibase_item","*":"Q446142"}]}}